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Significance for Public Health 
The impact of the COVID-19 pandemic on public health in the United States has been 
significant. Due to the ever-evolving nature of the pandemic, healthcare workers and public 
health experts require a thorough understanding of the clinical outcomes of hospitalized 
COVID-19 patients. This study found that despite decreases in overall mortality rates as the 
pandemic continues, certain demographic groups including the elderly and Black non-
Hispanics remain disproportionately affected. Such information could inform ongoing care of 
COVID-19 patients as well as shape public health policies to address health disparities to 





Background: The United States has experienced high COVID-19 case counts, 
hospitalizations, and death rates. This retrospective analysis reports changing trends in the 
demographics and clinical outcomes of hospitalized US COVID-19 patients between April 
and August 2020.  
Design and Methods: The Premier Healthcare Database Special Release was used to 
examine patient demographics of hospitalized COVID-19 patients from all US Census 
Bureau divisions. Demographics included age, sex, race, and ethnicity. Clinical outcomes 
included in-hospital mortality, intensive care unit (ICU) admission, and receipt of invasive 
mechanical ventilation. 
Results: Overall, 146,491 hospitalized COVID-19 patients were included (mean [SD] age, 
61.0 [18.4] years; 51.7% male; 29.6% White non-Hispanic). Monthly total hospitalizations 
decreased from 44,854 in April to 18,533 in August; ICU admissions increased from 19.8% 
to 23.6%, and ventilator use and inpatient mortality decreased from 18.6% to 14.5% and 
21.0% to 11.4%, respectively. Inpatient mortality was highest in the Middle Atlantic division 
(20.3%), followed by the New England (19.0%), East North Central (14.2%), and Mountain 
(13.7%) divisions. Black non-Hispanic patients were overrepresented among hospitalizations 
(19.0%); this group comprises 12.2% of the US population. Patients aged <65 years made up 
53% of hospitalizations and had lower inpatient mortality than those aged ≥65 years.  
Conclusions: Hospitalizations, ventilator use, and mortality decreased, while ICU admission 
rates increased from April to August 2020. Older individuals and Black non-Hispanics were 
found to be at elevated risk of severe outcomes. These trends could inform ongoing patient 




Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated 
disease (COVID-19) emerged as a global threat to public health in 2020.1 On March 11, 
2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic, 
owing to the rapidly increasing number of global cases and deaths.1 Globally, mitigation 
strategies including movement restrictions, face coverings, social distancing, and temporary 
closures of nonessential businesses successfully reduced widespread transmission of SARS-
CoV-22,3; however, many countries are now seeing a resurgence in the spread of SARS-CoV-
2 following the relaxation of stay-at-home orders and the reopening of economies.3,4 As of 
March 4, 2021, more than 114.8 million confirmed cases of COVID-19 and more than 2.5 
million attributed deaths have been reported worldwide.5  
The United States in particular has faced a heavy COVID-19 case count and death toll; as 
of March 4, 2021, there have been more than 28.5 million cases, resulting in over 500,000 
deaths.6 The overall number and rate of hospitalizations remains an important indicator of 
COVID-19 burden and severity; recent national surveillance data show rising hospitalization 
rates and report that certain populations face greater risk of hospitalization than others.7 Data 
from ongoing surveillance studies and retrospective analyses have consistently demonstrated 
that male sex, older age, and underlying comorbidities are substantial risk factors for poor 
clinical outcomes following COVID-19 diagnosis.7-10 Additionally, certain racial and ethnic 
groups in the United States are disproportionately affected by COVID-19 and experience 
poor outcomes,10,11 potentially due to disparities in education, income, and healthcare access 
and utilization.12  
In the absence of universal federal guidelines, strategies to limit the spread of SARS-
CoV-2 in the United States have been left to the jurisdiction of individual states and 
territories.13 Between March 1 and May 31, 2020, 42 states and territories issued mandatory 
stay-at-home orders of varying duration and stringency.13 Consequently, the number of 
COVID-19 cases and deaths have varied considerably among US geographic regions.6 
Further, certain areas that had successfully limited the spread of SARS-CoV-2 are now seeing 
increases in case counts, likely fueled by the reopening of many states’ economies.3,6,13 
This retrospective analysis reports changing trends in the demographics and clinical 
outcomes of hospitalized COVID-19 patients in various US Census divisions between April 
and August 2020. Such information is crucial to inform regional healthcare providers and 






This retrospective observational study used the Premier Healthcare Database Special 
Release (PHD-SR), which was specifically developed for COVID-19 research.14 The PHD-
SR is a hospital-based, service-level, all-payer database containing information on inpatient 
discharges and hospital-based outpatient visits from nonprofit, nongovernmental community 
and teaching hospitals and health systems from urban and rural areas of the United States. 
The PHD-SR contains information from a subset of >800 facilities that submit data on a 
weekly, biweekly, or monthly basis with an approximate data lag time of 1 to 3 weeks from 
date of discharge. Institutional review board approval was not required for this study because 
the PHD-SR is a statistically de-identified data set and is Health Insurance Portability and 
Accountability Act (HIPAA) compliant. 
Patients with laboratory-confirmed infection of SARS-CoV-2, regardless of clinical signs 
or symptoms, are assigned the International Classification of Diseases, Tenth Revision, 
Clinical Modification (ICD-10-CM) diagnosis code U07.1.15,16 For this study, patients 
admitted in January 2020 or later with a discharge diagnosis of ICD-10-CM U07.1 were 
identified in the PHD-SR and included in the analysis. For patients with multiple encounters 
for COVID-19 during the study time frame, the first encounter was included in this study. 
The ICD-10-CM code U07.1 officially came into effect on April 1, 2020,17 and this study 
included records through August 2020; therefore, only patients discharged between April 1 
and August 31 (inclusive of these dates) are included. Demographic variables of interest 
included age, sex, race (White, Black, Other [Asian, American Indian and Alaska Native, 
Native Hawaiian, and other Pacific Islander, and those reporting more than 2 races], or 
unknown), ethnicity (Hispanic, non-Hispanic, or unknown), and census division. Race and 
ethnicity designations in PHD-SR are patient self-reported and follow the Centers for 
Medicaid and Medicare Services 1450/UB-04 uniform billing form. “Race/Ethnicity” 
combined categories were generated by combining both race and ethnicity fields; these 
included Asian Hispanic, Asian non-Hispanic, Black Hispanic, Black non-Hispanic, White 
Hispanic, White non-Hispanic, Other Hispanic, Other non-Hispanic, and Unknown, which 
includes patients with missing race and/or ethnicity information. “Race/Ethnicity” is 
“unknown” if a patient declines to self-report race and ethnicity information or if this 
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information is not collected at hospital admission. Additional hospitalization and patient 
characteristics of interest included length of hospitalization, intensive care unit (ICU) 
admission, length of stay in ICU, ventilator use, and death during hospitalization.  
 
Outcomes 
The primary outcomes of interest were overall in-hospital mortality, admission to the 
ICU, and receipt of invasive mechanical ventilation. Outcomes were defined using a 
combination of ICD-10-CM, Current Procedural Terminology, and discharge status codes as 
well as standard hospital service charge descriptions. Patient demographics were examined 
across each of the primary outcomes to evaluate the role of demographic factors on the risk of 
hospitalization and subsequent in-hospital clinical outcomes. Data were analyzed by month to 
determine COVID-19 outcomes among hospitalized patients during the mandatory stay-at-
home order period (from study start in April 2020 through May 31, 2020)13 and during the 
period when parts of the country were reopening (June through August 2020).  
 
Statistical Analysis 
Descriptive statistical analyses were performed to calculate the proportion of confirmed 
COVID-19 hospitalizations that required treatment in the ICU or invasive mechanical 
ventilation, as well as COVID-19 hospitalizations that resulted in in-hospital mortality. 
Binary and categorical variables were summarized as counts and proportions of the total 
study population and by subgroups when appropriate. Continuous variables were summarized 
as means and standard deviations (SD). 
 
Results 
A total of 146,491 patients hospitalized in the United States between April and August 
2020 were included in this analysis (mean [SD] age, 61.0 [18.4] years; 51.7% male; 29.6% 
White non-Hispanic; Table 1). Most patients were from the Middle Atlantic census division 
(27.2%), followed by South Atlantic (24.3%), East North Central (11.8%), and West South 





Among all patients admitted between April and August 2020, the mean (SD) length of 
hospitalization was 9.0 (9.6) days, 22.5% were admitted to the ICU, 16.3% received 
mechanical ventilation, and the overall mortality rate was 14.7% (Table 1). Total COVID-19 
hospitalizations decreased from 44,854 in April to 18,533 in August, albeit with a spike in 
July (n=35,988; Figure 1A). While hospitalizations decreased, the percentage of COVID-19 
hospitalized patients admitted to the ICU increased from April to May and June (from 19.8% 
to 26.5% and 25.2%, respectively), and fell to 20.7% in July before rising again in August to 
23.6% (Figure 1B). Despite higher rates of ICU admission, both ventilator use and inpatient 
mortality decreased from 18.6% to 14.5% and from 21.0% to 11.4%, respectively, between 
April and August (Figure 1B). 
 
Outcomes by Age  
The mean (SD) age of patients hospitalized during the study period was 61.0 (18.4) years 
(Table 1). Overall, 53.2% of hospitalized patients were aged <65 years, ranging from 48.7% 
in April to 59.4% in June. Within age groups (<65 vs ≥65 years), similar percentages of 
hospitalizations, ICU admissions, and ventilator use were reported in April (Figure 1C, D). 
As with the overall population, there was an increase in the percentage of patients admitted to 
the ICU in both age groups from April to May and June. Ventilator use and deaths in the <65-
year age group generally decreased over the same time frame.  
During the study period, patients aged ≥65 years consistently had higher inpatient 
mortality compared with those aged <65 years (Figure 1C, D). Monthly trends show that 
inpatient mortality decreased steadily in patients aged <65 years from 9.9% in April to 5.3% 
in July, after which there was a slight increase in August (6.2%). In comparison, there was a 
sharp decrease in inpatient mortality among patients aged ≥65 years, from 31.5% in April to 
16.6% in June, after which inpatient mortality remained relatively stable in this age group.  
 
Outcomes by Race, Ethnicity, and Geographic Division 
Overall, non-Hispanic patients accounted for the majority of hospitalizations during the 
study period (56.2%), followed by Hispanic patients (21.9%) and patients with unknown 
ethnicity (21.8%). White non-Hispanic patients accounted for the largest share of 
hospitalizations (29.6%), followed by Black non-Hispanics (19.0%; Table 1). Black non-
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Hispanic patients were overrepresented for hospitalizations, as they account for 12.2% of the 
total US population. Similarly, monthly trends showed that even though White non-Hispanics 
accounted for the largest proportion of hospitalized patients, ICU admission, ventilator use, 
and deaths, Black non-Hispanics were the most overrepresented demographic group for all 4 
categories relative to their national representation (Figure 2). The overrepresentation of 
Black non-Hispanics for hospitalization was also observed on the individual census division 
level, for example, comprising up to 14.7% and 30.3% of the monthly hospitalizations in 
West North Central and East North Central divisions, respectively (Supplementary Table 
1).  
The mean (SD) length of hospitalization during the study period was similar among the 
census divisions, ranging from 8.0 (8.2) to 10.0 (10.9) days (Supplementary Table 1). 
Among the 9 census divisions, Middle Atlantic and New England saw sharp increases in the 
mean length of hospitalization between April and June, followed by declines in July and 
August; similar trends for mean length of ICU stay and the percentage of patients receiving 
mechanical ventilation were also observed for the Middle Atlantic and New England census 
divisions. The Middle Atlantic census division experienced the greatest overall inpatient 
mortality (20.3%) during the study period, followed by New England (19.0%), East North 
Central (14.2%), and Mountain (13.7%) census divisions (Supplementary Table 1). There 
were consistent reductions in monthly inpatient mortality for all census divisions between 
April and June, after which there was an increase in July and August for all census divisions 
except East North Central and Middle Atlantic, where inpatient mortality remained steady for 
July and August.  
 When race and geography were jointly assessed, Black non-Hispanics were 
disproportionately at risk of hospitalization during each month of the study period in several 
census divisions including the East North Central, East South Central, Middle Atlantic, South 
Atlantic, West North Central, and West South Central divisions (Supplementary Table 1). 
Further analysis of clinical outcomes across race and ethnicity categories revealed that for all 
races and ethnicities, adults aged <65 years were at lower risk of ICU admission, ventilator 
use, and death (Figure 3) compared with individuals aged ≥65 years (Figure 4). Within each 
age group, no discernible differences in clinical outcomes were observed between race and 





 To our knowledge, this is one of the largest studies to date describing hospitalized 
COVID-19 patients in the United States. A total of 146,491 patients from all 9 US census 
divisions were included in this analysis of monthly patient data from April to August 2020. 
The data from this study show a general trend of decreasing total hospitalizations and 
inpatient mortality in the United States during the study period. However, 2 peaks in overall 
hospitalizations were observed, the first occurring in April and the second in July. These data 
are consistent with those reported by the US Centers for Disease Control and Prevention 
(CDC), which reported peak weekly hospitalization rates for all ages in mid-April, followed 
by a second peak in mid-July.19 In mid-March 2020, states began issuing stay-at-home orders 
in anticipation of the first surge in cases and the second peak may have resulted from the 
lifting of these orders.13  
Inpatient mortality reported early in the study in April (21.0%) is in line with several 
other studies from the United States that reported inpatient mortality rates ranging from 10% 
to 50% at the time.20-23 In this study, inpatient mortality rates decreased to 11.4% by August, 
consistent with the 6.6% to 10.7% mortality rates reported by the CDC for the last 2 weeks of 
August 2020.19 Declining case fatality rates have also been reported in other countries, even 
in the face of increasing hospitalization rates.24,25 Potential reasons for improvements in 
clinical outcomes could be a combination of improved and timely diagnosis, changing 
practices regarding ventilator use, better pharmacologic treatments such as systemic 
corticosteroids and remdesivir, better community awareness of the disease, and lower viral 
load exposure due to mask wearing and adherence to social distancing guidelines.2,3,26-29 
In this study, a change in the age distribution of hospitalized COVID-19 patients was 
observed over time, with a trend toward an increasing proportion of hospitalized patients who 
were in the group aged <65 years. Similarly, the CDC has reported shifts in the age 
distribution of patients diagnosed with COVID-19 in the United States, with the largest 
increases reported between May and July in individuals aged <30 years.30 Additionally, the 
WHO reported that between February and July 2020, the proportion of global cases in 
patients aged 0 to 4 years, 5 to 24 years, and 25 to 64 years increased by 3- to 7-fold 
depending on the age group.31 These shifts could be a consequence of the easing of social 
distancing and public health measures, which might lead to increased transmission among the 
younger age groups.31 Additionally, a survey by the CDC observed that individuals aged 18 
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to 29 years were less likely to engage in thorough COVID-19 mitigation behaviors, including 
mask wearing, maintaining appropriate social distance, and avoiding public and crowded 
places compared with individuals aged ≥60 years32; such behaviors could further contribute 
to greater rates of infection among younger individuals. In this study, despite individuals 
aged <65 years making up 53% of COVID-19 hospitalizations overall, inpatient mortality 
was still consistently lower than for patients aged ≥65 years, consistent with observations 
from other studies throughout the pandemic.33,34 Additionally, inpatient mortality for patients 
aged ≥65 years also decreased over time, potentially attributable to improvements in 
diagnosis, patient management, and treatment.26-28 
Several studies have consistently reported that racial and ethnic minorities are 
disproportionately affected by COVID-19.10,11,35,36 In this study, Black non-Hispanics were 
overrepresented relative to their national population in several census divisions, occasionally 
by over 2-fold. Most prominently, Black non-Hispanics make up only 6.4% of the population 
in the West North Central and 11.9% in the East North Central divisions37 yet comprised up 
to 14.7% and 30.3% of the monthly hospitalizations in these divisions, respectively. Of note, 
this study did not account for comorbidities and socioeconomic status. These characteristics 
will be important to address in future work because longstanding systemic health and social 
inequities are known to put racial and ethnic minorities at increased risk of illness.12 
Additionally, mandatory restrictions enacted during the pandemic could have put such 
patients at further disadvantage of obtaining timely care, thus putting them at further risk for 
COVID-19 and at risk of higher burden of disease and poor outcomes.12  
Limitations 
This study should be considered in light of several limitations inherent to analyses using 
administrative data. The PHD-SR contains patient-level data extracted from hospital 
discharge billing files and, as such, longitudinal baseline and follow-up data (ie, preadmission 
and postdischarge) are not available. Additionally, the PHD-SR includes patient self-reported 
data and could therefore be subject to reporting error.  
Conclusions 
This descriptive analysis provides important information relating to US COVID-19 
hospitalization and mortality trends from April to August 2020, including the time periods in 
which many states implemented and then lifted stay-at-home orders. The study demonstrated 
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that hospitalizations, ventilator use, and mortality have decreased over the course of the study 
period, while ICU admission rates have remained fairly constant. Other themes, including 
worse clinical outcomes for older patients and the disproportionate hospitalization among 
Black non-Hispanics, remained consistent throughout the study period. The results of this 
study are important for informing ongoing patient care as well as public health policies to 
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Figure 1. Total Hospitalizations (A), Clinical Outcomes for Patients Hospitalized With 
COVID-19 by Discharge Month for (B) All Patients, (C) <65 Years Age Group, and (D) 
≥65 Years Age Group. COVID-19=coronavirus disease-19; ICU=intensive care unit. 
 
Figure 2. Distribution of Race and Ethnicity Among US Patients Hospitalized With 
COVID-19 by Discharge Month for (A) Hospitalizations, (B) ICU Admissions, (C) 
Ventilator Use, and (D) Mortality. COVID-19=coronavirus disease-19; ICU=intensive care 
unit. Other=Native Hawaiian and Other Pacific Islander, American Indian and Alaska Native, 
and Some Other race. Unknown=all patients missing information on race and/or ethnicity. 
 
Figure 3. Clinical Outcomes of US Patients Aged <65 Years Hospitalized With COVID-
19 Stratified by Race or Ethnicity for (A) Black, (B) Hispanic, (C) Asian, (D) White, and 
(E) Other Race. 
 COVID-19=coronavirus disease-19; ICU=intensive care unit. Other=Native Hawaiian and 
Other Pacific Islander, American Indian and Alaska Native, and Some Other race. Panels A, 
C, D, and E are by race, regardless of ethnicity; panel B is by ethnicity regardless of race.  
 
Figure 4. Clinical Outcomes of US Patients Aged ≥65 Years Hospitalized With COVID-
19 Stratified by Race or Ethnicity for (A) Black, (B) Hispanic, (C) Asian, (D) White, and 
(E) Other Race. 
COVID-19=coronavirus disease-19; ICU=intensive care unit. Other=Native Hawaiian and 
Other Pacific Islander, American Indian and Alaska Native, and Some Other race. Panels A, 










Mean (SD) age, y 61.0 (18.4) 
Age group, n (%)  
<65 y 77,910 (53.2) 
≥65 y 68,581 (46.8) 
Sex, n (%)  
Male 75,771 (51.7) 
Female 70,602 (48.2) 
Unknown 118 (0.1) 
Race, n (%)  
Asian 3943 (2.7) 
Black 33,630 (23.0) 
Otherb 25,176 (17.2) 
White 74,394 (50.8) 
Unknownc 9348 (6.4) 
Ethnicity, n (%)  
Hispanic 32,138 (21.9) 
Unknownc  31,995 (21.8) 
Race and ethnicity, n (%) US Population Estimate, %a  
Asian Hispanic 0.1 58 (0) 
Asian non-Hispanic 4.7 3278 (2.2) 
Black Hispanic 0.4 489 (0.3) 
Black non-Hispanic 12.2 27,839 (19.0) 
White Hispanic 8.7 15,688 (10.7) 
White non-Hispanic 63.8 43,351 (29.6) 
Other Hispanicb 6.2 11,205 (7.7) 
Other non-Hispanicb 1.1 5418 (3.7) 
Unknownc - 39,165 (26.7) 
US Census Division, n (%)  
East North Central 17,209 (11.8) 
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East South Central 8722 (6.0) 
Middle Atlantic 39,864 (27.2) 
Mountain 10,137 (7.0) 
New England 3850 (2.6) 
Pacific 8363 (5.7) 
South Atlantic 35,635 (24.3) 
West North Central 5597 (3.8) 
West South Central 17,114 (11.7) 
Length of hospitalization, days  
Mean (SD)  9.0 (9.6) 
Median (1st–3rd quartiles) 6 (3–11) 
ICU admission, n (%) 32,950 (22.5) 
Mean (SD) length of ICU stay, days 9.0 (10.3) 
Median (1st–3rd quartiles) length of ICU stay, days 6 (2–13) 
Ventilator use, n (%) 23,897 (16.3) 
Deaths, n (%) 21,563 (14.7) 
COVID-19=coronavirus disease-19; ICU=intensive care unit. 
aBased on 2018 American Community Survey 1-Year Estimates available at census.gov. 
bIncludes Native Hawaiian and Other Pacific Islander, American Indian and Alaska Native, and Some Other 
race. 
cIncludes all patients missing information on race and/or ethnicity.  
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Figure 1. Total Hospitalizations (A), Clinical Outcomes for Patients Hospitalized With COVID-19 by Discharge Month for (B) 
All Patients, (C) <65 Years Age Group and (D) ≥65 Years Age Group.   
 

















Stay-at-home order in place Reopening for parts of the US
BA











































Stay-at-home order in place Reopening for parts of the US

















Stay-at-home order in place Reopening for parts of the US
ICU Admissions Ventilator Use Deaths
21 
 
Figure 2. Distribution of Race and Ethnicity Among US Patients Hospitalized With COVID-19 by Discharge Month for (A) 
Hospitalizations, (B) ICU Admissions, (C) Ventilator Use, and (D) Mortality.  
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Figure 3. Clinical Outcomes of US Patients Aged <65 Years Hospitalized With COVID-19 Stratified by Race or Ethnicity for 
(A) Black, (B) Hispanic, (C) Asian, (D) White, and (E) Other Race. 
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Figure 4. Clinical Outcomes of US Patients Aged ≥65 Years Hospitalized With COVID-19 Stratified by Race or Ethnicity for 
(A) Black, (B) Hispanic, (C) Asian, (D) White, and (E) Other Race  
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Supplementary Table 1. Characteristics of Patients Hospitalized With COVID-19 by US Census Division  
 April May June July August April–August 
East North Central 
(Wisconsin, Michigan, 
Illinois, Indiana, Ohio) 
n=6377 n=3926 n=2128 n=2620 n=2158 N=17,209 
Mean (SD) age, y 65.0 (16.2) 62.0 (18.4) 61.0 (18.9) 60.0 (18.8) 63.0 (18.3) 63.0 (17.8) 
Sex, n (%)       
Male 3286 (51.5) 1998 (50.9) 1037 (48.7) 1355 (51.7) 1051 (48.7) 8727 (50.7) 
Female 3050 (47.8) 1887 (48.1) 1076 (50.6) 1254 (47.9) 1103 (51.1) 8370 (48.6) 
Unknown 41 (0.6) 41 (1.0) 15 (0.7) 11 (0.4) 4 (0.2) 112 (0.7) 
Race, n (%)       
Asian 94 (1.5) 111 (2.8) 58 (2.7) 41 (1.6) 24 (1.1) 328 (1.9) 
Black 2578 (40.4) 1109 (28.2) 569 (26.7) 872 (33.3) 411 (19.0) 5539 (32.2) 
Otherb 474 (7.4) 545 (13.9) 230 (10.8) 131 (5.0) 121 (5.6) 1501 (8.7) 
White 3018 (47.3) 1986 (50.6) 1182 (55.5) 1454 (55.5) 1514 (70.2) 9154 (53.2) 
Unknownc 213 (3.3) 175 (4.5) 89 (4.2) 122 (4.7) 88 (4.1) 687 (4.0) 
Ethnicity, n (%)       
Hispanic 373 (5.9) 603 (15.4) 356 (16.7) 222 (8.5) 193 (8.9) 1747 (10.2) 
















0.0 2 (0) 3 (0.1) 2 (0.1) 1 (0) 0 (0) 8 (0.1) 
Asian non-
Hispanic 
2.7 70 (1.1) 100 (2.6) 54 (2.5) 37 (1.4) 22 (1.0) 283 (1.6) 
Black 
Hispanic 
0.2 7 (0.1) 7 (0.2) 3 (0.1) 3 (0.1) 1 (0.1) 21 (0.1) 
Black non-
Hispanic 
11.9 1294 (20.3) 833 (21.2) 515 (24.2) 794 (30.3) 403 (18.7) 3839 (22.3) 
White 
Hispanic 
3.8 124 (1.9) 223 (5.7) 165 (7.8) 115 (4.4) 92 (4.3) 719 (4.2) 
White non-
Hispanic 
75.7 2101 (33.0) 1502 (38.3) 956 (45.0) 1244 (47.5) 1394 (64.6) 7197 (41.8) 
Other 
Hispanicb 
3.1 197 (3.1) 285 (7.3) 124 (5.8) 47 (1.8) 47 (2.2) 700 (4.1) 
Other non-
Hispanicb 
0.5 210 (3.3) 186 (4.7) 82 (3.9) 67 (2.6) 69 (3.2) 614 (3.6) 
Unknownc - 2372 (37.2) 787 (20.1) 227 (10.7) 312 (11.9) 130 (6.0) 3828 (22.2) 
Length of hospitalization, 
days 
      





6.0 (3.0–10.0) 6.0 (3.0–12.0) 6.0 (3.0–
13.0) 
5.0 (2.0–8.0) 5.0 (3.0–9.0) 6.0 (3.0–11.0) 
ICU admission, n (%) 1683 (26.4) 1196 (30.5) 698 (32.8) 675 (25.8) 573 (26.6) 4825 (28.0) 
Mean (SD) length of ICU 
stay, days 
8.0 (7.0) 11.0 (10.4) 11.0 (11.8) 8.0 (10.1) 8.0 (10.5) 9.0 (9.7) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
6.0 (3.0–12.0) 7.0 (3–15.0) 7.0 (3.0–
16.0) 
5.0 (2.0–10.0) 4.0 (2.0–10.0) 6.0 (2.0–12.0) 
Ventilator use, n (%) 1412 (22.1) 801 (20.4) 390 (18.3) 304 (11.6) 263 (12.2) 3170 (18.4) 
Deaths, n (%) 1258 (19.7) 535 (13.6) 239 (11.2) 226 (8.6) 189 (8.8) 2447 (14.2) 
East South Central 
(Kentucky, Tennessee, 
Mississippi, Alabama) 
n=864 n=806 n=1289 n=3089 n=2674 N=8722 
Mean (SD) age, y 63.0 (16.1) 64.0 (17.5) 60.0 (18.5) 61.0 (17.6) 64.0 (17.0) 62.0 (17.5) 
Sex, n (%)       
Male 388 (44.9) 339 (42.1) 574 (44.5) 1442 (46.7) 1294 (48.4) 4037 (46.3) 
Female 476 (55.1) 467 (58.0) 715 (55.5) 1647 (53.3) 1380 (51.6) 4685 (53.7) 
Unknown 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Race, n (%)       
Asian 8 (0.9) 4 (0.5) 3 (0.2) 15 (0.5) 8 (0.3) 38 (0.4) 
Black 344 (39.8) 294 (36.5) 538 (41.7) 1154 (37.4) 833 (31.2) 3163 (36.3) 
Otherb 71 (8.2) 125 (15.5) 143 (11.1) 189 (6.1) 110 (4.1) 638 (7.3) 
White 416 (48.1) 343 (42.6) 525 (40.7) 1619 (52.4) 1647 (61.6) 4550 (52.2) 
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Unknownc 25 (2.9) 40 (5.0) 80 (6.2) 112 (3.6) 76 (2.8) 333 (3.8) 
Ethnicity, n (%)       
Hispanic 56 (6.5) 58 (7.2) 99 (7.7) 147 (4.8) 73 (2.7) 433 (5.0) 










      
Asian 
Hispanic 
0.0 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Asian non-
Hispanic 
1.2 8 (0.9) 2 (0.3) 3 (0.2) 13 (0.4) 8 (0.3) 34 (0.4) 
Black 
Hispanic 
0.1 3 (0.4) 6 (0.7) 2 (0.2) 3 (0.1) 0 (0) 14 (0.2) 
Black non-
Hispanic 
20.2 307 (35.5) 270 (33.5) 512 (39.7) 1086 (35.2) 821 (30.7) 2996 (34.4) 
White 
Hispanic 
1.6 41 (4.8) 43 (5.3) 36 (2.8) 58 (1.9) 31 (1.2) 209 (2.4) 
White non-
Hispanic 
73.1 264 (30.6) 209 (26.0) 407 (31.6) 1325 (42.9) 1524 (57.0) 3729 (42.8) 
Other 
Hispanicb 





0.5 58 (6.7) 115 (14.3) 82 (6.4) 104 (3.4) 69 (2.6) 428 (4.9) 
Unknownc - 174 (20.1) 153 (19.0) 198 (15.4) 433 (14.0) 192 (7.2) 1150 (13.2) 
Length of hospitalization, 
days 
      
Mean (SD) 8.0 (6.4) 10.0 (10.3) 8.0 (9.5) 7.0 (7.2) 8.0 (8.7) 8.0 (8.3) 
Median (1st–3rd 
quartiles) 
6.0 (3.0–10.0) 6.0 (3.0–13.0) 5.0 (3.0–
10.0) 
5.0 (3.0–9.0) 5.0 (3.0–10.0) 5.0 (3.0–10.0) 
ICU admission, n (%) 227 (26.3) 188 (23.3) 261 (20.3) 536 (17.4) 530 (19.8) 1742 (20.0) 
Mean (SD) length of ICU 
stay, days 
7.0 (6.1) 11.0 (10.9) 8.0 (9.4) 7.0 (9.0) 8.0 (9.1) 8.0 (9.0) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
6.0 (2.0–11.0) 6.0 (3.0–16.0) 4.0 (2.0–
10.0) 
4.0 (2.0–9.0) 5.0 (2.0–10.0) 5.0 (2.0–11.0) 
Ventilator use, n (%) 204 (23.6) 162 (20.1) 178 (13.8) 356 (11.5) 356 (13.3) 1256 (14.4) 
Deaths, n (%) 171 (19.8) 124 (15.4) 131 (10.2) 325 (10.5) 326 (12.2) 1077 (12.4) 
Middle Atlantic (New 
York, Pennsylvania, New 
Jersey) 
n=25,075 n=9430 n=2921 n=1577 n=861 N=39,864 
Mean (SD) age, y 64.0 (16.9) 63.0 (18.6) 61.0 (19.4) 58.0 (20.3) 57.0 (21.0) 63.0 (17.8) 
Sex, n (%)       
Male 14,008 (55.9) 4896 (51.9) 1502 (51.4) 784 (49.7) 427 (49.6) 21,617 (54.2) 
Female 11,067 (44.1) 4534 (48.1) 1419 (48.6) 792 (50.2) 434 (50.4) 18,246 (45.8) 
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Unknown 0 (0) 0 (0) 0 (0) 1 (0) 0 (0) 1 (0) 
Race, n (%)       
Asian 1091 (4.4) 315 (3.3) 94 (3.2) 47 (3.0) 19 (2.2) 1566 (3.9) 
Black 5296 (21.1) 1976 (21.0) 552 (18.9) 348 (22.1) 174 (20.2) 8346 (20.9) 
Otherb 6854 (27.3) 2404 (25.5) 708 (24.2) 340 (21.6) 233 (27.1) 10,539 (26.4) 
White 8591 (34.3) 3814 (40.4) 1287 (44.1) 680 (43.1) 389 (45.2) 14,761 (37.0) 
Unknownc 3243 (12.9) 921 (9.8) 280 (9.6) 162 (10.3) 46 (5.3) 4652 (11.7) 
Ethnicity, n (%)       
Hispanic 4541 (18.1) 1621 (17.2) 584 (20.0) 312 (19.8) 176 (20.4) 7234 (18.1) 










      
Asian 
Hispanic 
0.1 7 (0) 4 (0) 0 (0) 1 (0) 0 (0) 12 (0) 
Asian non-
Hispanic 
6.0 953 (3.8) 271 (2.9) 82 (2.8) 42 (2.7) 14 (1.6) 1362 (3.4) 
Black 
Hispanic 
1.0 82 (0.3) 28 (0.3) 9 (0.3) 4 (0.3) 2 (0.2) 125 (0.3) 
Black non-
Hispanic 





6.3 749 (3.0) 238 (2.5) 66 (2.3) 36 (2.3) 20 (2.3) 1109 (2.8) 
White non-
Hispanic 
65.1 6,180 (24.7) 2777 (29.5) 990 (33.9) 529 (33.5) 307 (35.7) 10,783 (27.0) 
Other 
Hispanicb 
5.5 2042 (8.1) 865 (9.2) 333 (11.4) 176 (11.2) 124 (14.4) 3540 (8.9) 
Other non-
Hispanicb 
0.5 1186 (4.7) 411 (4.4) 124(4.3) 58 (3.7) 35 (4.1) 1814 (4.6) 
Unknownc - 9513 (37.9) 3185 (33.8) 838 (28.7) 415 (26.3) 204 (23.7) 14155 (35.5) 
Length of hospitalization, 
days 
      
Mean (SD) 8.0 (6.5) 12.0 (12.3) 16.0 (19.2) 13.0 (20.2) 9.0 (15.7) 10.0 (10.9) 
Median (1st–3rd 
quartiles) 
6.0 (3.0–10.0) 8.0 (4.0–17.0) 8.0 (4.0–
21.0) 
5.0 (2.0–12.0) 5.0 (2.0–9.0) 6.0 (3.0–12.0) 
ICU admission, n (%) 3630 (14.5) 2201 (23.3) 811 (27.8) 333 (21.1) 150 (17.4) 7125 (17.9) 
Mean (SD) length of ICU 
stay, days 
7.0 (6.5) 12.0 (11.5) 16.0 (16.5) 15.0 (19.1) 12.0 (23.7) 10.0 (11.5) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
5.0 (2.0–10.0) 9.0 (3.0–18.0) 10.0 (4.0–
23.0) 
7.0 (2.0–20.0) 4.0 (1.0–11.0) 6.0 (2.0–14.0) 
Ventilator use, n (%) 4292 (17.1) 2099 (22.3) 653 (22.4) 223 (14.1) 84 (9.8) 7351 (18.4) 




Idaho, Wyoming, Nevada, 
Utah, Colorado, Arizona, 
New Mexico) 
n=1082 n=1006 n=2017 n=4667 n=1365 N=10,137 
Mean (SD) age, y 60.0 (17.0) 61.0 (17.9) 55.0 (18.8) 59.0 (17.8) 59.0 (18.3) 58.0 (18.1) 
Sex, n (%)       
Male 580 (53.6) 539 (53.6) 1041 (51.6) 2364 (50.7) 697 (51.1) 5221 (51.5) 
Female 502 (46.4) 467 (46.4) 976 (48.4) 2303 (49.4) 668 (48.9) 4916 (48.5) 
Unknown 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Race, n (%)       
Asian 57 (5.3) 39 (3.9) 57 (2.8) 150 (3.2) 27 (2.0) 330 (3.3) 
Black 90 (8.3) 65 (6.5) 135 (6.7) 316 (6.8) 92 (6.7) 698 (6.9) 
Otherb 287 (26.5) 217 (21.6) 337 (16.7) 750 (16.1) 158 (11.6) 1749 (17.3) 
White 623 (57.6) 660 (65.6) 1446 (71.7) 3374 (72.3) 1076 (78.8) 7179 (70.8) 
Unknownc 25 (2.3) 25 (2.5) 42 (2.1) 77 (1.6) 12 (0.9) 181 (1.8) 
Ethnicity, n (%)       
Hispanic 71 (6.6) 59 (5.9) 62 (3.1) 322 (6.9) 2 (0.1) 516 (5.1) 
















0.1 0 (0) 0 (0) 0 (0) 1 (0) 0 (0) 1 (0) 
Asian non-
Hispanic 
2.7 39 (3.6) 20 (2.0) 17 (0.8) 75 (1.6) 0 (0) 151 (1.5) 
Black 
Hispanic 
0.3 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Black non-
Hispanic 
3.2 52 (4.8) 22 (2.2) 28 (1.4) 114 (2.4) 0 (0) 216 (2.1) 
White 
Hispanic 
12.3 4 (0.4) 2 (0.2) 5 (0.3) 14 (0.3) 0 (0) 25 (0.3) 
White non-
Hispanic 
65.3 127 (11.7) 89 (8.8) 84 (4.2) 318 (6.8) 6 (0.4) 624 (6.2) 
Other 
Hispanicb 
9.6 63 (5.8) 53 (5.3) 57 (2.8) 306 (6.6) 0 (0) 479 (4.7) 
Other non-
Hispanicb 
3.2 40 (3.7) 16 (1.6) 25 (1.2) 109 (2.3) 0 (0) 190 (1.9) 
Unknownc - 757 (70.0) 804 (79.9) 1801 (89.3) 3730 (79.9) 1359 (99.6) 8451 (83.4) 
Length of hospitalization, 
days 
      
Mean (SD) 8.0 (7.2) 11.0 (10.6) 8.0 (9.3) 8.0 (8.1) 13.0 (12.7) 9.0 (9.4) 
Median (1st–3rd 
quartiles) 
6.0 (3.0–11.0) 7.0 (3.0–14.0) 5.0 (3.0–
9.0) 
6.0 (3.0–11.0) 7.0 (4.0–17.0) 6.0 (3.0–11.0) 
ICU admission, n (%) 319 (29.5) 338 (33.6) 404 (20.0) 951 (20.4) 461 (33.8) 2473 (24.4) 
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Mean (SD) length of ICU 
stay, days 
8.0 (6.9) 12.0 (11.5) 10.0 (12.4) 10.0 (10.3) 14.0 (13.7) 11.0 (11.4) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
6.0 (3.0–11.0) 8.0 (3.0–18.0) 6.0 (2.0–
13.5) 
7.0 (3.0–14.0) 10.0 (3.0–22.0) 7.0 (3.0–15.0) 
Ventilator use, n (%) 261 (24.1) 242 (24.1) 254 (12.6) 700 (15.0) 343 (25.1) 1800 (17.8) 
Deaths, n (%) 186 (17.2) 153 (15.2) 183 (9.1) 647 (13.9) 215 (15.8) 1384 (13.7) 





n=1729 n=1441 n=445 n=159 n=76 N=3850 
Mean (SD) age, y 68.0 (16.3) 66.0 (17.3) 66.0 (18.4) 61.0 (20.2) 64.0 (16.8) 67.0 (17.2) 
Sex, n (%)       
Male 899 (52.0) 723 (50.2) 221 (49.7) 77 (48.4) 33 (43.4) 1953 (50.7) 
Female 830 (48.0) 717 (49.8) 224 (50.3) 82 (51.6) 43 (56.60 1896 (49.3) 
Unknown 0 (0) 1 (0) 0 (0) 0 (0) 0 (0) 1 (0) 
Race, n (%)       
Asian 27 (1.6) 14 (1.0) 5 (1.1) 4 (2.5) 6 (7.9) 56 (1.5) 
Black 267 (15.4) 210 (14.6) 44 (9.9) 16 (10.1) 9 (11.8) 546 (14.2) 
Otherb 242 (14.0) 265 (18.4) 69 (15.5) 24 (15.1) 6 (7.9) 606 (15.7) 
White 1165 (67.4) 931 (64.6) 319 (71.7) 112 (70.4) 55 (72.4) 2582 (67.1) 
Unknownc 28 (1.6) 21 (1.5) 8 (1.8) 3 (1.9) 0 (0) 60 (1.6) 
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Ethnicity, n (%)       
Hispanic 150 (8.7) 158 (11.0) 60 (13.5) 27 (17.0) 17 (22.4) 412 (10.7) 











      
Asian 
Hispanic 
0.0 1 (0) 0 (0) 0 (0) 1 (0.6) 0 (0) 2 (0) 
Asian non-
Hispanic 
3.9 17 (1.0) 9 (0.6) 3 (0.7) 1 (0.6) 5 (6.6) 35 (0.9) 
Black 
Hispanic 
0.6 7 (0.4) 4 (0.3) 2 (0.5) 1 (0.6) 1 (1.3) 15 (0.4) 
Black non-
Hispanic 
5.6 129 (7.5) 93 (6.5) 19 (4.3) 11 (6.9) 8 (10.5) 260 (6.8) 
White 
Hispanic 
4.1 119 (6.9) 90 (6.3) 41 (9.2) 18 (11.3) 12 (15.8) 280 (7.3) 
White non-
Hispanic 
78.9 613 (35.5) 452 (31.4) 187 (42.0) 62 (39.0) 42 (55.3) 1356 (35.2) 
Other 
Hispanicb 





0.9 19 (1.1) 13 (0.9) 5 (1.1) 1 (0.6) 2 (2.6) 40 (1.0) 
Unknownc - 802 (46.4) 717 (49.8) 173 (38.9) 59 (37.1) 2 (2.6) 1753 (45.5) 
Length of hospitalization, 
days 
      
Mean (SD) 8.0 (6.3) 10.0 (9.9) 14.0 (15.9) 12.0 (16.9) 10.0 (9.7) 9.0 (10.1) 
Median (1st–3rd 
quartiles) 
6.0 (3.0–10.0) 6.0 (3.0–13.0) 8.0 (4.0–
17.0) 
6.0 (3.0–12.0) 7.0 (4.0–12.5) 6.0 (4.0–11.0) 
ICU admission, n (%) 333 (19.3) 314 (21.8) 128 (28.8) 28 (17.6) 9 (11.8) 812 (21.1) 
Mean (SD) length of ICU 
stay, days 
7.0 (5.8) 10.0 (10.5) 13.0 (13.20 16.0 (16.5) 10.0 (11.0) 9.0 (10.0) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
5.0 (2.0–10.0) 7.0 (3.0–15.0) 7.0 (3.0–
19.0) 
11.0 (3.0–28.0) 8.0 (2.0–12.0) 6.0 (2.0–13.0) 
Ventilator use, n (%) 300 (17.4) 267 (18.5) 102 (22.9) 20 (12.6) 7 (9.2) 696 (18.1) 




n=1134 n=1164 n=1524 n=2927 n=1614 N=8363 
Mean (SD) age, y 61.0 (17.4) 60.0 (18.4) 56.0 (19.4) 56.0 (19.1) 56.0 (19.7) 57.0 (19.1) 
Sex, n (%)       
Male 632 (55.7) 640 (55.0) 806 (52.9) 1608 (54.9) 841 (52.1) 4527 (54.1) 
Female 502 (44.3) 523 (44.9) 718 (47.1) 1319 (45.1) 773 (47.9) 3835 (45.9) 
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Unknown 0 (0) 1 (0) 0 (0) 0 (0) 0 (0) 1 (0) 
Race, n (%)       
Asian 108 (9.5) 47 (4.0) 67 (4.4) 113 (3.9) 78 (4.8) 413 (4.9) 
Black 75 (6.6) 81 (7.0) 80 (5.3) 170 (5.8) 87 (5.4) 493 (5.9) 
Otherb 307 (27.1) 363 (31.2) 496 (32.5) 845 (28.9) 424 (26.3) 2435 (29.1) 
White 584 (51.5) 635 (54.6) 842 (55.2) 1712 (58.5) 950 (58.9) 4723 (56.5) 
Unknownc 60 (5.3) 38 (3.3) 39 (2.6) 87 (3.0) 75 (4.6) 299 (3.6) 
Ethnicity, n (%)       
Hispanic 392 (34.6) 500 (43.0) 752 (49.3) 1376 (47.0) 644 (39.9) 3664 (43.8) 











      
Asian 
Hispanic 
0.2 0 (0) 0 (0) 2 (0.1) 1 (0) 0 (0) 3 (0) 
Asian non-
Hispanic 
11.9 85 (7.5) 37 (3.2) 42 (2.8) 87 (3.0) 48 (3.0) 299 (3.6) 
Black 
Hispanic 
0.3 1 (0) 1 (0) 1 (0) 3 (0.1) 1 (0) 7 (0.1) 
Black non-
Hispanic 





14.2 201 (17.7) 288 (24.7) 467 (30.6) 868 (29.7) 364 (22.6) 2188 (26.2) 
White non-
Hispanic 
47.3 316 (27.8) 257 (22.1) 253 (16.6) 533 (18.2) 313 (19.4) 1672 (20.0) 
Other 
Hispanicb 
1.6 155 (13.7) 182 (15.6) 255 (16.7) 456 (15.6) 228 (14.1) 1276 (15.3) 
Other non-
Hispanicb 
1.6 64 (5.6) 63 (5.4) 62 (4.1) 164 (5.6) 92 (5.7) 445 (5.3) 
Unknownc - 250 (22.1) 282 (24.2) 377 (24.7) 686 (23.4) 507 (31.4) 2102 (25.1) 
Length of hospitalization, 
days 
      
Mean (SD) 9.0 (7.1) 11.0 (11.0) 8.0 (9.7) 8.0 (8.4) 9.0 (11.7) 9.0 (9.7) 
Median (1st–3rd 
quartiles) 
7.0 (4.0–11.0) 7.0 (4.0–15.0) 5.0 (3.0–
10.0) 
5.0 (3.0–9.0) 6.0 (3.0–11.0) 6.0 (3.0–10.0) 
ICU admission, n (%) 335 (29.5) 344 (29.6) 346 (22.7) 579 (19.8) 394 (24.4) 1998 (23.9) 
Mean (SD) length of ICU 
stay, days 
7 (5.8) 11 (11.2) 8 (9.4) 9 (9.4) 9 (9.9) 9 (9.4) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
5.0 (2.0–10.0) 6.0 (2.0–17.0) 5.0 (2.0–
12.0) 
5.0 (2.0–12.0) 6.0 (2.0–14.0) 5.0 (2.0–12.0) 
Ventilator use, n (%) 234 (20.6) 238 (20.5) 179 (11.8) 378 (12.9) 298 (18.5) 1327 (15.9) 
Deaths, n (%) 208 (18.3) 186 (16.0) 172 (11.3) 296 (10.1) 178 (11.0) 1040 (12.4) 
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South Atlantic (West 
Virginia, Virginia, North 
Carolina, South Carolina, 
Georgia, Florida, 
Delaware, Maryland, 
District of Columbia) 
n=5747 n=6389 n=6088 n=12,431 n=4980 N=35,635 
Mean (SD) age, y 61.0 (17.7) 61.0 (18.6) 58.0 (19.3) 60.0 (18.3) 61.0 (19.1) 60.0 (18.6) 
Sex, n (%)       
Male 2965 (51.6) 3258 (51.0) 3047 (50.1) 6330 (50.9) 2467 (49.5) 18,067 (51.0) 
Female 2782 (48.4) 3131 (49.0) 3041 (50.0) 6101 (49.1) 2513 (50.5) 17,568 (49.3) 
Unknown 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Race, n (%)       
Asian 157 (2.7) 205 (3.2) 124 (2.0) 113 (0.9) 64 (1.3) 663 (1.9) 
Black 1844 (32.1) 1899 (29.7) 1716 (28.2) 3365 (27.1) 1565 (31.4) 10,389 (29.2) 
Otherb 1109 (19.3) 1615 (25.3) 1097 (18.0) 1102 (8.9) 519 (10.4) 5442 (15.3) 
White 2446 (42.6) 2321 (36.3) 2775 (45.6) 7238 (58.2) 2591 (52.0) 17,371 (48.7) 
Unknownc 191 (3.3) 349 (5.5) 376 (6.2) 613 (4.9) 241 (4.8) 1770 (5.0) 
Ethnicity, n (%)       
Hispanic 1454 (25.3) 1870 (29.3) 2077 (34.1) 4548 (36.6) 1135 (22.8) 11,084 (31.1) 
















0.0 6 (0.1) 9 (0.1) 3 (0.1) 4 (0) 3 (0.1) 25 (0.1) 
Asian non-
Hispanic 
3.1 143 (2.5) 189 (3.0) 114 (1.9) 99 (0.8) 56 (1.1) 601 (1.7) 
Black 
Hispanic 
0.5 53 (0.9) 31 (0.5) 47 (0.8) 105 (0.8) 43 (0.9) 279 (0.8) 
Black non-
Hispanic 
21.4 1691 (29.4) 1745 (27.3) 1551 (25.5) 3004 (24.2) 1361 (27.3) 9352 (26.2) 
White 
Hispanic 
7.6 629 (10.9) 496 (7.8) 976 (16.0) 3282 (26.4) 676 (13.6) 6059 (17.0) 
White non-
Hispanic 
60.8 1659 (28.9) 1645 (25.8) 1665 (27.4) 3576 (28.8) 1629 (32.7) 10174 (28.55) 
Other 
Hispanicb 
3.5 666 (11.6) 1136 (17.8) 784 (12.9) 717 (5.8) 265 (5.3) 3568 (10.0) 
Other non-
Hispanicb 
0.6 293 (5.1) 323 (5.1) 190 (3.1) 244 (2.0) 142 (2.9) 1192 (3.35) 
Unknownc - 607 (10.6) 815 (12.8) 758 (12.5) 1400 (11.3) 805 (16.2) 4385 (12.3) 
Length of hospitalization, 
days 
      





6.0 (3.0–10.0) 6.0 (3.0–13.0) 5.0 (3.0–
11.0) 
5.0 (3.0–9.0) 6.0 (3.0–11.0) 5.0 (3.0–10.0) 
ICU admission, n (%) 1468 (25.5) 1582 (24.8) 1309 (21.5) 1910 (15.4) 841 (16.9) 7110 (20.0) 
Mean (SD) length of ICU 
stay, days 
8.0 (6.5) 11.0 (10.6) 10.0 (11.6) 8.0 (10.4) 10.0 (11.3) 9.0 (10.2) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
6.0 (2.0–11.0) 7.0 (3.0–15.0) 6.0 (2.0–
14.0) 
5.0 (2.0–10.0) 6.0 (2.0–13.0) 6.0 (2.0–13.0) 
Ventilator use, n (%) 1082 (18.8) 1108 (17.3) 785 (12.9) 1208 (9.7) 645 (13.0) 4828 (13.6) 
Deaths, n (%) 955 (16.6) 860 (13.5) 529 (8.7) 1110 (8.9) 540 (10.8) 3994 (11.2) 
West North Central 
(North Dakota, South 
Dakota, Minnesota, Iowa, 
Nebraska, Kansas, 
Missouri) 
n=897 n=1519 n=943 n=1068 n=1170 N=5597 
Mean (SD) age, y 61.0 (18.2) 58.0 (19.8) 57.0 (19.8) 59.0 (20.0) 61.0 (19.4) 59.0 (19.6) 
Sex, n (%)       
Male 495 (55.2) 755 (49.7) 487 (51.6) 537 (50.3) 620 (53.0) 2894 (51.7) 
Female 402 (44.8) 764 (50.3) 456 (48.4) 531 (49.7) 550 (47.0) 2703 (48.3) 
Unknown 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Race, n (%)       
Asian 47 (5.2) 120 (7.9) 63 (6.7) 34 (3.2) 46 (3.9) 310 (5.5) 
Black 128 (14.3) 231 (15.2) 118 (12.5) 136 (12.7) 131 (11.2) 744 (13.3) 
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Otherb 60 (6.7) 155 (10.2) 111 (11.8) 99 (9.3) 64 (5.5) 489 (8.7) 
White 610 (68.0) 933 (61.4) 595 (63.1) 740 (69.3) 864 (73.8) 3742 (66.9) 
Unknownc 52 (5.8) 80 (5.3) 56 (5.9) 59 (5.5) 65 (5.6) 312 (5.6) 
Ethnicity, n (%)       
Hispanic 160 (17.8) 310 (20.4) 241 (25.6) 172 (16.1) 169 (14.4) 1052 (18.8) 











      
Asian 
Hispanic 
0.0 1 (0.1) 2 (0.1) 0 (0) 1 (0) 0 (0) 4 (0) 
Asian non-
Hispanic 
2.3 44 (4.9) 112 (7.4) 60 (6.4) 30 (2.8) 45 (3.9) 291 (5.2) 
Black 
Hispanic 
0.1 0 (0) 1 (0.1) 0 (0) 0 (0) 3 (0.3) 4 (0) 
Black non-
Hispanic 
6.4 126 (14.1) 223 (14.7) 116 (12.3) 133 (12.5) 123 (10.5) 721 (12.9) 
White 
Hispanic 
2.7 110 (12.3) 214 (14.1) 177 (18.8) 113 (10.6) 114 (9.7) 728 (13.0) 
White non-
Hispanic 





2.2 33 (3.7) 63 (4.2) 42 (4.5) 46 (4.3) 33 (2.8) 217 (3.9) 
Other non-
Hispanicb 
1.3 24 (2.7) 80 (5.3) 61 (6.5) 46 (4.3) 23 (2.0) 234 (4.2) 
Unknownc - 65 (7.3) 128 (8.4) 86 (9.1) 93 (8.7) 115 (9.8) 487 (8.7) 
Length of hospitalization, 
days 
      
Mean (SD) 7.0 (6.3) 8.0 (8.2) 10.0 (10.8) 8.0 (10.1) 7.0 (8.1) 8.0 (8.9) 
Median (1st–3rd 
quartiles) 
5.0 (3.0–10.0) 5.0 (3.0–11.0) 6.0 (3.0–
13.0) 
5.0 (2.0–10.0) 5.0 (2.0–8.0) 5.0 (3.0–10.0) 
ICU admission, n (%) 247 (27.5) 444 (29.2) 322 (34.2) 270 (25.3) 313 (26.8) 1596 (28.5) 
Mean (SD) length of ICU 
stay, days 
8.0 (6.4) 8.0 (7.7) 11.0 (10.9) 8.0 (10.3) 8.0 (9.6) 9.0 (9.2) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
7.0 (2.0–11.0) 5.0 (2.0–12.0) 7.0 (2.0–
15.0) 
4.0 (2.0–10.0) 5.0 (2.0–10.0) 6.0 (2.0–12.0) 
Ventilator use, n (%) 177 (19.7) 267 (17.6) 202 (21.4) 128 (12.0) 131 (11.2) 905 (16.2) 
Deaths, n (%) 118 (13.2) 197 (13.0) 108 (11.5) 94 (8.8) 130 (11.1) 647 (11.6) 
West South Central 
(Oklahoma, Arkansas, 
Louisiana, Texas) 
n=1949 n=1559 n=2521 n=7450 n=3635 N=17,114 
Mean (SD) age, y 62.0 (17.2) 60.0 (17.6) 56.0 (18.8) 59.0 (18.7) 60.0 (18.9) 59.0 (18.6) 
Sex, n (%)       
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Male 1026 (52.6) 803 (51.5) 1249 (49.5) 3799 (51.0) 1851 (50.9) 8728 (51.0) 
Female 923 (47.4) 756 (48.5) 1272 (50.5) 3649 (49.0) 1783 (49.0) 8383 (49.0) 
Unknown 0 (0) 0 (0) 0 (0) 2 (0) 1 (0) 3 (0) 
Race, n (%)       
Asian 21 (1.1) 21 (1.3) 76 (3.0) 90 (1.2) 31 (0.9) 239 (1.4) 
Black 649 (33.3) 458 (29.4) 501 (19.9) 1347 (18.1) 757 (20.8) 3712 (21.7) 
Otherb 150 (7.7) 224 (14.4) 286 (11.3) 755 (10.1) 362 (10.0) 1777 (10.4) 
White 1059 (54.3) 785 (50.4) 1475 (58.5) 4786 (64.2) 2227 (61.3) 10,332 (60.4) 
Unknownc 70 (3.6) 71 (4.6) 183 (7.3) 472 (6.3) 258 (7.1) 1054 (6.2) 
Ethnicity, n (%)       
Hispanic 302 (15.5) 407 (26.1) 986 (39.1) 3222 (43.2) 1079 (29.7) 5996 (35.0) 











      
Asian 
Hispanic 
0.1 0 (0) 1 (0.1) 1 (0) 0 (0) 1 (0) 3 (0) 
Asian non-
Hispanic 
3.1 18 (0.9) 19 (1.2) 73 (2.9) 84 (1.1) 28 (0.8) 222 (1.3) 
Black 
Hispanic 





13.9 444 (22.8) 353 (22.6) 450 (17.9) 1212 (16.3) 661 (18.2) 3120 (18.2) 
White 
Hispanic 
18.2 196 (10.1) 226 (14.5) 698 (27.7) 2486 (33.4) 765 (21.1) 4371 (25.6) 
White non-
Hispanic 
51.9 615 (31.6) 433 (27.8) 581 (23.1) 1969 (26.4) 1307 (36.0) 4905 (28.7) 
Other 
Hispanicb 
8.3 76 (3.9) 153 (9.8) 201 (8.0) 519 (7.0) 205 (5.6) 1154 (6.7) 
Other non-
Hispanicb 
1.4 52 (2.7) 54 (3.5) 61 (2.4) 168 (2.3) 126 (3.5) 461 (2.7) 
Unknownc - 543 (27.9) 318 (20.4) 452 (17.9) 1002 (13.5) 539 (14.8) 2854 (16.7) 
Length of hospitalization, 
days 
      
Mean (SD) 8.0 (6.5) 10.0 (9.9) 7.0 (8.3) 7.0 (7.2) 9.0 (9.7) 8.0 (8.2) 
Median (1st–3rd 
quartiles) 
6.0 (3.0–10.0) 6.0 (3.0–12.0) 5.0 (2.0–
8.0) 
5.0 (3.0–9.0) 5.0 (3.0–11.0) 5.0 (3.0–10.0) 
ICU admission, n (%) 642 (32.9) 623 (40.0) 728 (28.9) 2168 (29.1) 1108 (30.5) 5269 (30.8) 
Mean (SD) length of ICU 
stay, days 
8.0 (7.0) 11.0 (10.6) 9.0 (11.4) 7.0 (7.8) 11.0 (11.3) 9.0 (9.6) 
Median (1st–3rd 
quartiles) length of ICU 
stay, days 
6.0 (3.0–12.0) 7.0 (3.0–15.0) 5.0 (2.0–
10.0) 
4.0 (2.0–10.0) 6.0 (3.0–15.0) 5.0 (2.0–11.0) 
Ventilator use, n (%) 396 (20.3) 312 (20.0) 287 (11.4) 1004 (13.5) 565 (15.5) 2564 (15.0) 
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Deaths, n (%) 303 (15.6) 196 (12.6) 223 (8.9) 981 (13.2) 454 (12.5) 2157 (12.6) 
COVID-19=coronavirus disease-19; ICU=intensive care unit. 
aBased on 2018 American Community Survey 1-Year Estimates available at census.gov. 
bIncludes Native Hawaiian and Other Pacific Islander, American Indian and Alaska Native, and Some Other race. 
cIncludes all patients missing information on race and/or ethnicity. 
